INNITIUS Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Investors
  • 16

INNITIUS General Information

Description

Developer of actionable diagnostic devices designed to improve women's health through the use of torsional waves. The company's devices utilize a patented intravaginal probe to transmit torsional waves for the diagnosis of conditions associated with changes in tissue consistency and threatened preterm labor events, enabling medical practitioners to detect false indications of premature birth.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BIC Bizkaia, Astondo Bidea
  • 612 Parque Tecnológico de Bizkaia, Derio
  • 48160 Bilbao
  • Spain
+34 944
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • BIC Bizkaia, Astondo Bidea
  • 612 Parque Tecnológico de Bizkaia, Derio
  • 48160 Bilbao
  • Spain
+34 944

INNITIUS Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INNITIUS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series A) In Progress Clinical Trials - Phase 2
14. Later Stage VC 03-Jul-2025 Completed Clinical Trials - Phase 2
13. Later Stage VC 12-Sep-2023 Completed Clinical Trials - General
12. Accelerator/Incubator 30-Jan-2023 Completed Clinical Trials - General
11. Grant 05-Oct-2022 Completed Clinical Trials - General
10. Accelerator/Incubator 01-Jan-2022 Completed Clinical Trials - General
9. Early Stage VC 01-Jan-2021 Completed Clinical Trials - General
8. Early Stage VC 25-Jun-2020 Completed Clinical Trials - General
7. Accelerator/Incubator 02-Jun-2020 $54.6K $1.51M Completed Clinical Trials - General
6. Angel (individual) $365K $1.45M Completed Startup
To view INNITIUS’s complete valuation and funding history, request access »

INNITIUS Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 62,800 $0.010820 $2.15 $2.15 1x $2.15 6.04%
Ordinary 90,300 $0.010820 $2.17 $2.17 1x $2.17 8.69%
To view INNITIUS’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

INNITIUS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of actionable diagnostic devices designed to improve women's health through the use of torsional waves. The co
Diagnostic Equipment
Bilbao, Spain
27 As of 2026

Marlborough, MA
 

Hilden, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

INNITIUS Competitors (2)

One of INNITIUS’s 2 competitors is Hologic, a Private Equity-Backed company based in Marlborough, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hologic Private Equity-Backed Marlborough, MA
Qiagen Formerly VC-backed Hilden, Germany
You’re viewing 2 of 2 competitors. Get the full list »

INNITIUS Patents

INNITIUS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-1300541-U Medical device for receiving a tight-shape membrane Active 31-Jan-2023
ES-1300541-Y Medical device to receive a mebrane in a tight shape Active 31-Jan-2023
ES-1298681-U Device for arranging a membrane in a probe Active 23-Jan-2023
ES-1298681-Y Device for arranging a membrane in a probe Active 23-Jan-2023
US-D1147389-S1 Intravaginal torsional wave probe Active 23-Jan-2023 A61B8/12
To view INNITIUS’s complete patent history, request access »

INNITIUS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INNITIUS Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clave Capital Hedge Fund Minority
Namarel Ventures Venture Capital Minority
Chemostart Accelerator/Incubator
European Innovation Council Accelerator/Incubator Minority
Key Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

INNITIUS FAQs

  • When was INNITIUS founded?

    INNITIUS was founded in 2018.

  • Where is INNITIUS headquartered?

    INNITIUS is headquartered in Bilbao, Spain.

  • What is the size of INNITIUS?

    INNITIUS has 27 total employees.

  • What industry is INNITIUS in?

    INNITIUS’s primary industry is Diagnostic Equipment.

  • Is INNITIUS a private or public company?

    INNITIUS is a Private company.

  • What is INNITIUS’s current revenue?

    The current revenue for INNITIUS is .

  • How much funding has INNITIUS raised over time?

    INNITIUS has raised $8.91M.

  • Who are INNITIUS’s investors?

    Clave Capital, Namarel Ventures, Chemostart, European Innovation Council, and Key Capital are 5 of 16 investors who have invested in INNITIUS.

  • Who are INNITIUS’s competitors?

    Hologic and Qiagen are competitors of INNITIUS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process